Promoters of progression of diabetic nephropathy: The relative roles of blood glucose and blood pressure control

Nephrology Dialysis Transplantation

Volumn 12, Issue SUPPL. 2, 1997, Pages 71-74

  Alaveras, A E G ^a   Thomas, S M ^a,b   Sagriotis, A ^a   Viberti, G C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Blood pressure; Control; Diabetic nephropathy; Glycaemic; HbA1; Progression; Proteinuria

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CHILD; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD;

EID: 0030760735     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, and Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983; 25: 496-501
2. Wang PH, Lau J, and Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 1993; 341: 1306-1309
3. Rudberg S, Ullman E, and Dahlquist G. Relationship between early metabolic control and the development of microalbuminuria-a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 1309-1314
4. Microalbuminuria Collaborative Study Group. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Br Med J 1993; 306: 1235-1239
5. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329; 977-986
6. Parving H-H, Andersen AR, Schmidt UM, Hommel E, Mathiesen ER, and Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987; 294: 1443-1447
7. Parving H-H et al. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Dis. 1993; 22: 188-195
8. Mogensen CE. Long term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 1982; 285: 685-688
9. Rossing P, Hommel E, Smidt UM, and Parving H-H. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 1993; 42: 715-719
10. Brøchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-274
11. Mogensen CE, Hansen KW, Mau Pederson M and Christensen CK. Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM. Diabetes Care 1991; 14(Suppl 4): 13-26
12. Gall M-A, Nielson FS, Smidt UM, and Parving H-H. The course of kidney function in type 2 (non-insulin dependent) diabetic patients with diabetic nephropathy (Abstract). Diabetologia 1992; (Suppl. 1): A147
13. Weidemann P, Boehlen LM, and de Courten M. Effects of different antihypertensive drugs on human diabetic proteinuria. Nephrol Dial Transplant 1993; 8: 582-584
14. Krolewski AS, Laffel LMB, Krowleski M, Quinn M, and Warram JH. Glycosylated haemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1251-1255
15. Viberti G, Keen H, Dodds R, and Bending JJ. Metabolic control and progression of diabetic nephropathy. Diabetologia 1987; 30: 481-482
16. Nyberg G, Blohme G, and Norden G. Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologia 1987; 30: 82-86
17. Mulec H, Blohme G, Grande B, and Bjorck S. Progression of overt diabetic nephropathy: Role of metabolic control. J Am Soc Nephrol 1995; 6: A434 p. 453
18. Manto A, Cotroneo P, Marra G et al. Effect of intensive treatment on diabetic nephropathy in patients with type 1 diabetes. Kidney Int 1995; 47: 231-235
19. Microalbuminuria Collaborative Study Group. Intensive Therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Br Med J 1995; 311: 973-977
20. Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995; 42: 1703-1720
21. Bending JJ, Viberti GC, Watkins PJ, and Keen H. Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. Br Med J 1986; 292: 83-86
22. Viberti GC, Bilous RW, Mackintosh D, Bending JJ, and Keen H. Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J 1983; 286: 598-602
23. Tamborlane WV, Puklin JE, Bergman M. Verdonk C, et al. Long term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care 1982; 5 [Suppl. 1]: 58-64
24. Bending JJ, Pickup JC, Viberti GC, and Keen H. Glycaemic control in diabetic nephropathy. Br Med J 1984; 288: 1187-1191